Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230776111> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4230776111 endingPage "288" @default.
- W4230776111 startingPage "288" @default.
- W4230776111 abstract "In the past few decades, a tremendous amount of effort has been invested in developing gene and cell therapies for inherited genetic diseases such as Huntington's disease (HD). However, progress in their clinical application has been very limited. One of the major barriers is the lack of appropriate animal models that allow precise prediction patterns in human patients. Most of the animal models used for gene and cell therapy study are primarily focused on safety and toxicity evaluation, while therapeutic efficacy cannot be fully addressed because they do not carry the same human diseases. Although mouse models of human diseases are available and have been widely used for the development of new therapies, mice are not good predictors for humans because of the fundamental differences (genome composition, body size, life span and metabolic mechanism) between humans and rodents. Although monkeys are one of the best models for studying pharmacokinetics and overall impact of treatment, they are primarily used for safety and toxicity evaluation. Even HD monkey models, created by chemical induction or focal gene transfer in the brain, develop similar cellular pathology, therapeutic efficacy and systemic evaluation cannot be determined, which is one of the major barriers in drug and therapeutic development. The development of transgenic HD monkeys has opened the door for a new paradigm of animal modeling for the advancement of novel gene and cell therapy. HD monkeys not only carry the genetic defect that leads to human HD, they also develop clinical features comparable to humans that no other animal model does. While testing in HD monkeys has yet to be achieved until a cohort of well characterized HD monkeys was established, iPS cell lines derived from HD monkeys with a board spectrum of HD pathology and clinical features are a unique in vitro model for studying HD pathogenesis and the development of novel therapeutic approaches. New knowledge and treatments generated from iPS cells can next be translated and applied in HD monkeys from whom the stem cells were derived, thus the goal of personalized medicine can also be evaluated. This work was funded by a grant from NCRR/NIH (R24RR018827)." @default.
- W4230776111 created "2022-05-11" @default.
- W4230776111 creator A5070607078 @default.
- W4230776111 date "2012-01-01" @default.
- W4230776111 modified "2023-09-27" @default.
- W4230776111 title "NEURODEGENERATIVE DISEASES" @default.
- W4230776111 doi "https://doi.org/10.1071/rdv24n1ab251" @default.
- W4230776111 hasPublicationYear "2012" @default.
- W4230776111 type Work @default.
- W4230776111 citedByCount "2" @default.
- W4230776111 countsByYear W42307761112021 @default.
- W4230776111 countsByYear W42307761112023 @default.
- W4230776111 crossrefType "journal-article" @default.
- W4230776111 hasAuthorship W4230776111A5070607078 @default.
- W4230776111 hasConcept C102230213 @default.
- W4230776111 hasConcept C104317684 @default.
- W4230776111 hasConcept C111472728 @default.
- W4230776111 hasConcept C111599444 @default.
- W4230776111 hasConcept C126322002 @default.
- W4230776111 hasConcept C138885662 @default.
- W4230776111 hasConcept C142724271 @default.
- W4230776111 hasConcept C169760540 @default.
- W4230776111 hasConcept C2778117688 @default.
- W4230776111 hasConcept C2779134260 @default.
- W4230776111 hasConcept C2780035454 @default.
- W4230776111 hasConcept C2988867146 @default.
- W4230776111 hasConcept C54355233 @default.
- W4230776111 hasConcept C60644358 @default.
- W4230776111 hasConcept C64903051 @default.
- W4230776111 hasConcept C70721500 @default.
- W4230776111 hasConcept C71924100 @default.
- W4230776111 hasConcept C86803240 @default.
- W4230776111 hasConcept C89611455 @default.
- W4230776111 hasConcept C98274493 @default.
- W4230776111 hasConceptScore W4230776111C102230213 @default.
- W4230776111 hasConceptScore W4230776111C104317684 @default.
- W4230776111 hasConceptScore W4230776111C111472728 @default.
- W4230776111 hasConceptScore W4230776111C111599444 @default.
- W4230776111 hasConceptScore W4230776111C126322002 @default.
- W4230776111 hasConceptScore W4230776111C138885662 @default.
- W4230776111 hasConceptScore W4230776111C142724271 @default.
- W4230776111 hasConceptScore W4230776111C169760540 @default.
- W4230776111 hasConceptScore W4230776111C2778117688 @default.
- W4230776111 hasConceptScore W4230776111C2779134260 @default.
- W4230776111 hasConceptScore W4230776111C2780035454 @default.
- W4230776111 hasConceptScore W4230776111C2988867146 @default.
- W4230776111 hasConceptScore W4230776111C54355233 @default.
- W4230776111 hasConceptScore W4230776111C60644358 @default.
- W4230776111 hasConceptScore W4230776111C64903051 @default.
- W4230776111 hasConceptScore W4230776111C70721500 @default.
- W4230776111 hasConceptScore W4230776111C71924100 @default.
- W4230776111 hasConceptScore W4230776111C86803240 @default.
- W4230776111 hasConceptScore W4230776111C89611455 @default.
- W4230776111 hasConceptScore W4230776111C98274493 @default.
- W4230776111 hasIssue "1" @default.
- W4230776111 hasLocation W42307761111 @default.
- W4230776111 hasOpenAccess W4230776111 @default.
- W4230776111 hasPrimaryLocation W42307761111 @default.
- W4230776111 hasRelatedWork W2088493877 @default.
- W4230776111 hasRelatedWork W2105824961 @default.
- W4230776111 hasRelatedWork W2157571916 @default.
- W4230776111 hasRelatedWork W2207231158 @default.
- W4230776111 hasRelatedWork W2228293239 @default.
- W4230776111 hasRelatedWork W2365243819 @default.
- W4230776111 hasRelatedWork W2436361330 @default.
- W4230776111 hasRelatedWork W3019791136 @default.
- W4230776111 hasRelatedWork W4385267273 @default.
- W4230776111 hasRelatedWork W56610921 @default.
- W4230776111 hasVolume "24" @default.
- W4230776111 isParatext "false" @default.
- W4230776111 isRetracted "false" @default.
- W4230776111 workType "article" @default.